BDSI kicked off the post-Labor Day investing season with two investor conference appearances and clinical presentations at the medical conference PainWeek. We participated in the investor conferences enabling us to revisit our fundamental thesis and get an update on the company. Like our follow-up article on CPRX, we are taking the same approach with BDSI because we believe that the market is now just beginning to appreciate the strong fundamentals of the Company as indicated by favorable supply/demand trends for the stock.
When our initial article on BDSI published, the technical signals were